Kleanthis Xanthopoulos Insider Profile
4 Followers
Kleanthis Xanthopoulos, Director at Seelos Therapeutics, holds 23.60K shares in Zosano Pharma (Ticker: ZSANQ), holds 55.73K shares in Seelos Therapeutics (Ticker: SEELQ), holds 83.92K shares in Regulus (Ticker: RGLS).
Kleanthis Xanthopoulos's Trading History
You May Also Like
Kleanthis Xanthopoulos insider profile FAQ
What is the percentage of profitable transactions made by Kleanthis Xanthopoulos?
The percentage of profitable transactions made by Kleanthis Xanthopoulos is 17%.
What is the average return per transaction made by Kleanthis Xanthopoulos?
The average return per transaction made by Kleanthis Xanthopoulos is -17.90%.
What stocks does Kleanthis Xanthopoulos hold?
Kleanthis Xanthopoulos holds: SEELQ, RGLS, ZSANQ, IONS stocks.
What was Kleanthis Xanthopoulos's most profitable transaction?
Kleanthis Xanthopoulos’s most profitable transaction was an Informative Sell of RGLS stock on October 14, 2014. The return on the trade was 6.20%.
What is Kleanthis Xanthopoulos's role in Seelos Therapeutics?
Kleanthis Xanthopoulos's role in Seelos Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
